CA
COGT icon

CoreCap Advisors’s Cogent Biosciences COGT Stock Holding History

CoreCap Advisors’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.4K Hold
62
– – ﹤0.01% 2494
2026
Q1 		$2.39K Hold
62
– – ﹤0.01% 2371
2025
Q4 		$2.2K Hold
62
– – ﹤0.01% 2453
2025
Q3 		$890 Hold
62
– – ﹤0.01% 2499
2025
Q2 		$445 Hold
62
– – ﹤0.01% 2530
2025
Q1 		$371 Buy
+62
New +$486 ﹤0.01% 2769

Other funds holding COGT

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
HIA
Harbor Investment Advisory Lutherville, Maryland $1.43B AUM 30.71% 1-Year Est. Return

CoreCap Advisors's COGT Position: Q2 2026 in Review

CoreCap Advisors held its Cogent Biosciences (COGT) position steady in Q2 2026 at 62 shares worth $2.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2494.

CoreCap Advisors first reported a position in COGT in Q1 2025 and has held it in 6 quarters since. 18 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

  • CoreCap Advisors held 62 shares of Cogent Biosciences worth $2.4K as of Q2 2026.
  • CoreCap Advisors left its Cogent Biosciences share count unchanged in Q2 2026.
  • Cogent Biosciences made up ﹤0.01% of CoreCap Advisors's portfolio in Q2 2026, its #2494 holding.
  • CoreCap Advisors first reported a position in Cogent Biosciences in Q1 2025 and has held it in 6 quarters since.
  • 18 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.